2013 Q4 Form 10-K Financial Statement

#000139681415000003 Filed on February 24, 2015

View on sec.gov

Income Statement

Concept 2013 Q4 2013 Q3 2013 Q2
Revenue $33.56M $23.26M $17.14M
YoY Change 221.19% 174.09% 38.86%
Cost Of Revenue $18.38M $14.79M $10.21M
YoY Change 89.99% 59.27% 52.79%
Gross Profit $15.19M $8.468M $6.927M
YoY Change 1852.19% -1157.18% 22.41%
Gross Profit Margin 45.25% 36.41% 40.41%
Selling, General & Admin $20.20M $15.32M $14.08M
YoY Change 50.75% 34.65% 35.22%
% of Gross Profit 133.0% 180.92% 203.26%
Research & Development $4.800M $5.962M $4.857M
YoY Change 50.0% 69.04% 159.46%
% of Gross Profit 31.6% 70.41% 70.12%
Depreciation & Amortization $1.700M $800.0K $800.0K
YoY Change 17.24% -11.11%
% of Gross Profit 11.19% 9.45% 11.55%
Operating Expenses $43.38M $36.07M $29.15M
YoY Change 65.09% 49.11% 53.67%
Operating Profit -$28.20M -$12.81M -$12.01M
YoY Change 10.57% -18.41% 81.26%
Interest Expense -$1.900M $1.892M $1.914M
YoY Change 533.33% 314.91% 287.45%
% of Operating Profit
Other Income/Expense, Net -$300.0K -$1.970M -$2.021M
YoY Change 50.0% 4951.28% 21.02%
Pretax Income -$12.00M -$14.78M -$14.03M
YoY Change -26.38% -6.1% 69.13%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$11.96M -$14.78M -$14.03M
YoY Change -26.86% -6.1% 69.13%
Net Earnings / Revenue -35.62% -63.56% -81.86%
Basic Earnings Per Share -$0.36 -$0.44 -$0.42
Diluted Earnings Per Share -$0.36 -$0.44 -$0.42
COMMON SHARES
Basic Shares Outstanding 33.54M shares 33.36M shares 33.08M shares
Diluted Shares Outstanding 33.36M shares 33.08M shares

Balance Sheet

Concept 2013 Q4 2013 Q3 2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $72.20M $81.80M $96.00M
YoY Change 75.67% 22.27% 13.88%
Cash & Equivalents $12.52M $3.383M $8.626M
Short-Term Investments $59.60M $78.50M $87.30M
Other Short-Term Assets $4.400M $4.500M $3.600M
YoY Change 29.41% 18.42% 12.5%
Inventory $15.56M $15.61M $14.22M
Prepaid Expenses
Receivables $14.59M $9.771M $7.756M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $106.8M $111.7M $121.5M
YoY Change 75.23% 31.2% 21.4%
LONG-TERM ASSETS
Property, Plant & Equipment $48.18M $45.94M $42.07M
YoY Change 23.18% 30.08% 40.38%
Goodwill $10.33M $9.539M $8.980M
YoY Change 24.48% 17.63% 12.25%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.402M $3.557M $3.712M
YoY Change 565.75% 549.09% 518.67%
Total Long-Term Assets $63.07M $60.71M $56.94M
YoY Change 23.35% 27.28% 33.11%
TOTAL ASSETS
Total Short-Term Assets $106.8M $111.7M $121.5M
Total Long-Term Assets $63.07M $60.71M $56.94M
Total Assets $169.8M $172.4M $178.4M
YoY Change 51.55% 29.79% 24.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.069M $1.559M $1.712M
YoY Change 19.46% -67.45% 328.0%
Accrued Expenses $17.89M $15.57M $12.26M
YoY Change 82.65% 19.46% 31.83%
Deferred Revenue
YoY Change
Short-Term Debt $99.00M $97.90M $0.00
YoY Change
Long-Term Debt Due $120.0M $900.0K $900.0K
YoY Change 12.5% -25.0%
Total Short-Term Liabilities $121.9M $117.0M $15.84M
YoY Change 761.42% 489.93% 3.93%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $96.89M
YoY Change -100.0% -100.0% 274.1%
Other Long-Term Liabilities $3.190M $2.911M $2.743M
YoY Change 40.22% 21.34% -61.9%
Total Long-Term Liabilities $3.190M $2.911M $99.64M
YoY Change -88.39% -89.35% 201.01%
TOTAL LIABILITIES
Total Short-Term Liabilities $121.9M $117.0M $15.84M
Total Long-Term Liabilities $3.190M $2.911M $99.64M
Total Liabilities $128.6M $123.3M $119.3M
YoY Change 178.3% 135.35% 146.73%
SHAREHOLDERS EQUITY
Retained Earnings -$296.4M -$284.5M -$269.7M
YoY Change 27.49% 31.59%
Common Stock $34.00K $34.00K $33.00K
YoY Change 3.03% 6.25%
Preferred Stock
YoY Change
Treasury Stock (at cost) $0.00 $2.000K $2.000K
YoY Change -100.0% 0.0%
Treasury Stock Shares 0.000 shares 1.065K shares 1.065K shares
Shareholders Equity $41.25M $49.12M $59.14M
YoY Change
Total Liabilities & Shareholders Equity $169.8M $172.4M $178.4M
YoY Change 51.55% 29.79% 24.86%

Cashflow Statement

Concept 2013 Q4 2013 Q3 2013 Q2
OPERATING ACTIVITIES
Net Income -$11.96M -$14.78M -$14.03M
YoY Change -26.86% -6.1% 69.13%
Depreciation, Depletion And Amortization $1.700M $800.0K $800.0K
YoY Change 17.24% -11.11%
Cash From Operating Activities -$6.900M -$9.840M -$13.31M
YoY Change -67.42% -11.99% -34.17%
INVESTING ACTIVITIES
Capital Expenditures -$2.800M -$4.700M -$1.740M
YoY Change -40.8% -24.92% -60.18%
Acquisitions
YoY Change
Other Investing Activities $18.02M $8.310M -$3.780M
YoY Change -33.48% 86.74% -91.25%
Cash From Investing Activities $15.22M $3.610M -$5.520M
YoY Change -31.93% -299.45% -88.39%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 820.0K 980.0K 1.180M
YoY Change 241.67% 292.0% -98.16%
NET CHANGE
Cash From Operating Activities -6.900M -9.840M -13.31M
Cash From Investing Activities 15.22M 3.610M -5.520M
Cash From Financing Activities 820.0K 980.0K 1.180M
Net Change In Cash 9.140M -5.250M -17.65M
YoY Change 543.66% -58.79% 369.41%
FREE CASH FLOW
Cash From Operating Activities -$6.900M -$9.840M -$13.31M
Capital Expenditures -$2.800M -$4.700M -$1.740M
Free Cash Flow -$4.100M -$5.140M -$11.57M
YoY Change -75.08% 4.47% -27.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014 dei Amendment Flag
AmendmentFlag
false
CY2014 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2014 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2014 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2014 dei Document Period End Date
DocumentPeriodEndDate
2014-12-31
CY2014 dei Document Type
DocumentType
10-K
CY2014 dei Entity Central Index Key
EntityCentralIndexKey
0001396814
CY2015Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
36236036 shares
CY2014 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2014 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2014Q2 dei Entity Public Float
EntityPublicFloat
1495161494 USD
CY2014 dei Entity Registrant Name
EntityRegistrantName
Pacira Pharmaceuticals, Inc.
CY2014 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2014 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2013Q4 pcrx Accrued End Of Term Fee Current
AccruedEndOfTermFeeCurrent
1625000 USD
CY2014Q4 pcrx Accrued End Of Term Fee Current
AccruedEndOfTermFeeCurrent
1625000 USD
CY2013Q4 pcrx Accrued Operating Expenses Current
AccruedOperatingExpensesCurrent
8001000 USD
CY2014Q4 pcrx Accrued Operating Expenses Current
AccruedOperatingExpensesCurrent
12094000 USD
CY2014 pcrx Ageof Children Pediatric Patientsto Study Exparel
AgeofChildrenPediatricPatientstoStudyEXPAREL
P2Y
CY2012 pcrx Amortization Of Other Assets And Unfavorable Lease Obligation
AmortizationOfOtherAssetsAndUnfavorableLeaseObligation
-239000 USD
CY2013 pcrx Amortization Of Other Assets And Unfavorable Lease Obligation
AmortizationOfOtherAssetsAndUnfavorableLeaseObligation
459000 USD
CY2014 pcrx Amortization Of Other Assets And Unfavorable Lease Obligation
AmortizationOfOtherAssetsAndUnfavorableLeaseObligation
487000 USD
CY2012 pcrx Amortization Of Unfavorable Lease Accrual
AmortizationOfUnfavorableLeaseAccrual
400000 USD
CY2013 pcrx Amortization Of Unfavorable Lease Accrual
AmortizationOfUnfavorableLeaseAccrual
100000 USD
CY2014 pcrx Amortization Of Unfavorable Lease Accrual
AmortizationOfUnfavorableLeaseAccrual
100000 USD
CY2014 pcrx Amount Received In Lockbox Restricted For Payment Of Royalty Interest
AmountReceivedInLockboxRestrictedForPaymentOfRoyaltyInterest
2500000.0 USD
CY2012 pcrx Antidilutive Securities Excludedfrom Computationof Earningsper Share Amount Treasury Stock Method
AntidilutiveSecuritiesExcludedfromComputationofEarningsperShareAmountTreasuryStockMethod
1400000 shares
CY2013 pcrx Antidilutive Securities Excludedfrom Computationof Earningsper Share Amount Treasury Stock Method
AntidilutiveSecuritiesExcludedfromComputationofEarningsperShareAmountTreasuryStockMethod
3400000 shares
CY2014 pcrx Antidilutive Securities Excludedfrom Computationof Earningsper Share Amount Treasury Stock Method
AntidilutiveSecuritiesExcludedfromComputationofEarningsperShareAmountTreasuryStockMethod
5400000 shares
CY2013Q4 pcrx Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
13000 USD
CY2014Q4 pcrx Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
13000 USD
CY2013Q4 pcrx Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
8000 USD
CY2014Q4 pcrx Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
93000 USD
CY2014 pcrx Beginning Period Prior To Product Expiration Allowed For Returning Product
BeginningPeriodPriorToProductExpirationAllowedForReturningProduct
P6M
CY2013Q4 pcrx Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.73
CY2014Q4 pcrx Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
13.44
CY2012 pcrx Class Of Warrant Or Right Value Of Warrant Issued With Debt
ClassOfWarrantOrRightValueOfWarrantIssuedWithDebt
1354000 USD
CY2013 pcrx Class Of Warrant Or Right Value Of Warrant Issued With Debt
ClassOfWarrantOrRightValueOfWarrantIssuedWithDebt
0 USD
CY2014 pcrx Class Of Warrant Or Right Value Of Warrant Issued With Debt
ClassOfWarrantOrRightValueOfWarrantIssuedWithDebt
0 USD
CY2012 pcrx Collaborative Licensing And Development Revenue
CollaborativeLicensingAndDevelopmentRevenue
18390000 USD
CY2013 pcrx Collaborative Licensing And Development Revenue
CollaborativeLicensingAndDevelopmentRevenue
972000 USD
CY2014 pcrx Collaborative Licensing And Development Revenue
CollaborativeLicensingAndDevelopmentRevenue
1287000 USD
CY2012 pcrx Compensationexpensefromemployeestockpurchaseplan
Compensationexpensefromemployeestockpurchaseplan
0 USD
CY2013 pcrx Compensationexpensefromemployeestockpurchaseplan
Compensationexpensefromemployeestockpurchaseplan
0 USD
CY2014 pcrx Compensationexpensefromemployeestockpurchaseplan
Compensationexpensefromemployeestockpurchaseplan
345000 USD
CY2012 pcrx Compensationexpensefromstockoptions
Compensationexpensefromstockoptions
4776000 USD
CY2013 pcrx Compensationexpensefromstockoptions
Compensationexpensefromstockoptions
11513000 USD
CY2014 pcrx Compensationexpensefromstockoptions
Compensationexpensefromstockoptions
24477000 USD
CY2012Q2 pcrx Contingent Payment Obligation Established For Sale Of Product In Connection With Acquisition
ContingentPaymentObligationEstablishedForSaleOfProductInConnectionWithAcquisition
2000000 USD
CY2014 pcrx Debt Instrument Convertible Conversion Premium Shares
DebtInstrumentConvertibleConversionPremiumShares
3500000.0 shares
CY2014Q4 pcrx Debt Instrument Convertible Conversion Value
DebtInstrumentConvertibleConversionValue
309000000 USD
CY2012 pcrx Debt Issuance On Issuance Of Warrants Value
DebtIssuanceOnIssuanceOfWarrantsValue
1354000 USD
CY2014 pcrx Debt Issuance On Issuance Of Warrants Value
DebtIssuanceOnIssuanceOfWarrantsValue
1184000 USD
CY2013Q4 pcrx Deferred Tax Assets Gross Netof Deferred Tax Liabilities Before Valuation Allowance
DeferredTaxAssetsGrossNetofDeferredTaxLiabilitiesBeforeValuationAllowance
121486000 USD
CY2014Q4 pcrx Deferred Tax Assets Gross Netof Deferred Tax Liabilities Before Valuation Allowance
DeferredTaxAssetsGrossNetofDeferredTaxLiabilitiesBeforeValuationAllowance
131341000 USD
CY2013Q4 pcrx Deferred Tax Assets Stock Based Compensation
DeferredTaxAssetsStockBasedCompensation
2622000 USD
CY2014Q4 pcrx Deferred Tax Assets Stock Based Compensation
DeferredTaxAssetsStockBasedCompensation
8487000 USD
CY2012 pcrx Effective Income Tax Rate Reconciliation Interest Expense Percent
EffectiveIncomeTaxRateReconciliationInterestExpensePercent
-0.0022
CY2013 pcrx Effective Income Tax Rate Reconciliation Interest Expense Percent
EffectiveIncomeTaxRateReconciliationInterestExpensePercent
0.0030
CY2014 pcrx Effective Income Tax Rate Reconciliation Interest Expense Percent
EffectiveIncomeTaxRateReconciliationInterestExpensePercent
0.1068
CY2014Q4 pcrx Employee Stock Purchase Plan Espp Sharesin Espp
EmployeeStockPurchasePlanESPPSharesinESPP
500000 shares
CY2014 pcrx Employee Stock Purchase Plan Numberof Shares Authorized
EmployeeStockPurchasePlanNumberofSharesAuthorized
500000 shares
CY2014 pcrx Employee Stock Purchase Plan Numberof Shares Available For Purchase
EmployeeStockPurchasePlanNumberofSharesAvailableForPurchase
484278 shares
CY2014Q4 pcrx Employee Stock Purchase Planfairvalue
EmployeeStockPurchasePlanfairvalue
0.85
CY2012 pcrx Equity Componentof Convertible Debt
EquityComponentofConvertibleDebt
0 USD
CY2013 pcrx Equity Componentof Convertible Debt
EquityComponentofConvertibleDebt
24936000 USD
CY2014 pcrx Equity Componentof Convertible Debt
EquityComponentofConvertibleDebt
0 USD
CY2013 pcrx Goodwill Recordedfor Earn Out Payments
GoodwillRecordedforEarnOutPayments
2031000 USD
CY2014 pcrx Goodwill Recordedfor Earn Out Payments
GoodwillRecordedforEarnOutPayments
5433000 USD
CY2014 pcrx Goodwill Recordedon Milestone Payments
GoodwillRecordedonMilestonePayments
8000000 USD
CY2014Q4 pcrx Income Tax Provision
IncomeTaxProvision
200000 USD
CY2012 pcrx Increase Decrease In Royalty Interest Obligation
IncreaseDecreaseInRoyaltyInterestObligation
1076000 USD
CY2013 pcrx Increase Decrease In Royalty Interest Obligation
IncreaseDecreaseInRoyaltyInterestObligation
434000 USD
CY2014 pcrx Increase Decrease In Royalty Interest Obligation
IncreaseDecreaseInRoyaltyInterestObligation
970000 USD
CY2013Q4 pcrx Long Term Debt Including Royalty Interest Obligation
LongTermDebtIncludingRoyaltyInterestObligation
100207000 USD
CY2014Q4 pcrx Long Term Debt Including Royalty Interest Obligation
LongTermDebtIncludingRoyaltyInterestObligation
103376000 USD
CY2014 pcrx Maximum Ageof Pediatric Patientsto Study Exparel
MaximumAgeofPediatricPatientstoStudyEXPAREL
P18Y
CY2014Q4 pcrx Maximum Fair Market Value Purchaseof Espp Shares
MaximumFairMarketValuePurchaseofESPPShares
25000 USD
CY2014 pcrx Minimum Ageof Pediatric Patientsto Study Exparel
MinimumAgeofPediatricPatientstoStudyEXPAREL
P12Y
CY2014 pcrx Minimum Cumulative Percentage Of Change In Ownership As Condition To Offset Taxable Income Or Tax
MinimumCumulativePercentageOfChangeInOwnershipAsConditionToOffsetTaxableIncomeOrTax
0.5
CY2014Q4 pcrx Non Us Net Operating Loss
NonUSNetOperatingLoss
300000 USD
CY2013 pcrx Number Of Major Customers
NumberOfMajorCustomers
3 customer
CY2014 pcrx Number Of Major Customers
NumberOfMajorCustomers
3 customer
CY2014Q4 pcrx Operating Loss Carryforwards Related To Stock Based Compensation
OperatingLossCarryforwardsRelatedToStockBasedCompensation
41300000 USD
CY2012Q2 pcrx Payment Obligation Arising Due To First Commercial Sale Of Product In Connection With Acquisition
PaymentObligationArisingDueToFirstCommercialSaleOfProductInConnectionWithAcquisition
10000000 USD
CY2012 pcrx Payment Of Contingent Consideration
PaymentOfContingentConsideration
10339000 USD
CY2013 pcrx Payment Of Contingent Consideration
PaymentOfContingentConsideration
2031000 USD
CY2014 pcrx Payment Of Contingent Consideration
PaymentOfContingentConsideration
13433000 USD
CY2014 pcrx Payment Period Of Royalty Interest From Restricted Amount In Lockbox
PaymentPeriodOfRoyaltyInterestFromRestrictedAmountInLockbox
P12M
CY2014 pcrx Percentage Of Royalty On Sale Of Product
PercentageOfRoyaltyOnSaleOfProduct
0.03
CY2014 pcrx Period After Product Expiration Upto Which Product Is Allowed To Be Returned
PeriodAfterProductExpirationUptoWhichProductIsAllowedToBeReturned
P12M
CY2013Q1 pcrx Proceeds From Sale Of Unused Net Operating Losses
ProceedsFromSaleOfUnusedNetOperatingLosses
400000 USD
CY2012 pcrx Proceeds From Shares Issued Under Employee Stock Purchase Plan
ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlan
0 USD
CY2013 pcrx Proceeds From Shares Issued Under Employee Stock Purchase Plan
ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlan
0 USD
CY2014 pcrx Proceeds From Shares Issued Under Employee Stock Purchase Plan
ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlan
1184000 USD
CY2013Q4 pcrx Product Returns Rebatesand Other Fees
ProductReturnsRebatesandOtherFees
1245000 USD
CY2014Q4 pcrx Product Returns Rebatesand Other Fees
ProductReturnsRebatesandOtherFees
2470000 USD
CY2013Q4 pcrx Royalty Interest Obligation
RoyaltyInterestObligation
1246000 USD
CY2014Q4 pcrx Royalty Interest Obligation
RoyaltyInterestObligation
276000 USD
CY2013Q4 pcrx Royalty Interest Obligation Current
RoyaltyInterestObligationCurrent
1020000 USD
CY2014Q4 pcrx Royalty Interest Obligation Current
RoyaltyInterestObligationCurrent
276000 USD
CY2013Q4 pcrx Royalty Interest Obligation Noncurrent
RoyaltyInterestObligationNoncurrent
226000 USD
CY2014Q4 pcrx Royalty Interest Obligation Noncurrent
RoyaltyInterestObligationNoncurrent
0 USD
CY2014 pcrx Shares Issued During Period Employee Stock Purchase Plan
SharesIssuedDuringPeriodEmployeeStockPurchasePlan
15722 shares
CY2012 pcrx Stock Issued During Period Proceeds Followon Public Offering Issues
StockIssuedDuringPeriodProceedsFollowonPublicOfferingIssues
62855000 USD
CY2013 pcrx Stock Issued During Period Proceeds Followon Public Offering Issues
StockIssuedDuringPeriodProceedsFollowonPublicOfferingIssues
0 USD
CY2014 pcrx Stock Issued During Period Proceeds Followon Public Offering Issues
StockIssuedDuringPeriodProceedsFollowonPublicOfferingIssues
110452000 USD
CY2012Q2 pcrx Stock Issued During Period Shares Follow On Public Offering Issues
StockIssuedDuringPeriodSharesFollowOnPublicOfferingIssues
6900000 shares
CY2012 pcrx Stock Issued During Period Value Follow On Public Offering Issues
StockIssuedDuringPeriodValueFollowOnPublicOfferingIssues
62855000 USD
CY2013 pcrx Stock Issued During Period Value Follow On Public Offering Issues
StockIssuedDuringPeriodValueFollowOnPublicOfferingIssues
110452000 USD
CY2012 pcrx Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
100000 USD
CY2013 pcrx Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
0 USD
CY2014 pcrx Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
0 USD
CY2014Q4 pcrx Total Goodwill Recordedfor Earn Out Payments
TotalGoodwillRecordedforEarnOutPayments
7800000 USD
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3069000 USD
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6758000 USD
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
14590000 USD
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
22366000 USD
CY2013Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
0 USD
CY2014Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
139000 USD
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
17885000 USD
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
28450000 USD
CY2013Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
1526000 USD
CY2014Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
3213000 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
12576000 USD
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
20114000 USD
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
5000 USD
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-80000 USD
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
337639000 USD
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
481334000 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
23956000 USD
CY2012 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4776000 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11513000 USD
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
24822000 USD
CY2012 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4776000 USD
CY2013 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11513000 USD
CY2014 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
24822000 USD
CY2012 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
831000 USD
CY2013 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
3959000 USD
CY2014 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
4139000 USD
CY2012 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2100000 USD
CY2013 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2100000 USD
CY2014 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
800000 USD
CY2012 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3889000 shares
CY2013 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5378000 shares
CY2014 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6039000 shares
CY2013Q4 us-gaap Assets
Assets
169820000 USD
CY2014Q4 us-gaap Assets
Assets
326072000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
106751000 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
214257000 USD
CY2013Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
59632000 USD
CY2014Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
143649000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
46168000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10126000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12515000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
37520000 USD
CY2012Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
10.97
CY2012Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
162885 shares
CY2013Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
58354 shares
CY2014Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
7216 shares
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
33636442 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36150620 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33636442 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36150620 shares
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
34000 USD
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
36000 USD
CY2012 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-52269000 USD
CY2013 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-63931000 USD
CY2014 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13801000 USD
CY2013Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
98961000 USD
CY2014Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
103100000 USD
CY2012 us-gaap Cost Of Revenue
CostOfRevenue
32139000 USD
CY2013Q1 us-gaap Cost Of Revenue
CostOfRevenue
11391000 USD
CY2013Q2 us-gaap Cost Of Revenue
CostOfRevenue
10214000 USD
CY2013Q3 us-gaap Cost Of Revenue
CostOfRevenue
14791000 USD
CY2013Q4 us-gaap Cost Of Revenue
CostOfRevenue
18376000 USD
CY2013 us-gaap Cost Of Revenue
CostOfRevenue
54772000 USD
CY2014Q1 us-gaap Cost Of Revenue
CostOfRevenue
18127000 USD
CY2014Q2 us-gaap Cost Of Revenue
CostOfRevenue
19954000 USD
CY2014Q3 us-gaap Cost Of Revenue
CostOfRevenue
20391000 USD
CY2014Q4 us-gaap Cost Of Revenue
CostOfRevenue
18968000 USD
CY2014 us-gaap Cost Of Revenue
CostOfRevenue
77440000 USD
CY2014Q4 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
3500000 shares
CY2013Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
21039000 USD
CY2014Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
16900000 USD
CY2013Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
2300000 USD
CY2014Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
4500000 USD
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1008000 USD
CY2014Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1426000 USD
CY2013Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
3212000 USD
CY2014Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
9508000 USD
CY2013Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
1707000 USD
CY2014Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
4065000 USD
CY2013Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
129993000 USD
CY2014Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
137624000 USD
CY2013Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2014Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
114819000 USD
CY2014Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
111086000 USD
CY2013Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
752000 USD
CY2014Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
588000 USD
CY2013Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
3248000 USD
CY2014Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
3494000 USD
CY2013Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
5149000 USD
CY2014Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
6043000 USD
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
1696000 USD
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
3861000 USD
CY2013Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
121486000 USD
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
131341000 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Financing Arrangements
DeferredTaxLiabilitiesFinancingArrangements
8507000 USD
CY2014Q4 us-gaap Deferred Tax Liabilities Financing Arrangements
DeferredTaxLiabilitiesFinancingArrangements
6283000 USD
CY2012 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
300000 USD
CY2013 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
600000 USD
CY2014 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
1000000 USD
CY2012 us-gaap Depreciation
Depreciation
3600000 USD
CY2013 us-gaap Depreciation
Depreciation
3700000 USD
CY2014 us-gaap Depreciation
Depreciation
9300000 USD
CY2012 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5648000 USD
CY2013 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5747000 USD
CY2014 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10035000 USD
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.71
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.42
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.44
CY2013Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.36
CY2014Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.34
CY2014Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2014Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2012 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.72
CY2013 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.93
CY2014 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.39
CY2013Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.71
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.42
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.44
CY2013Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.36
CY2014Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.34
CY2014Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2014 us-gaap Income Taxes Paid
IncomeTaxesPaid
34000 USD
CY2012 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1386000 USD
CY2014Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
CY2012 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0000
CY2013 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0069
CY2014 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0128
CY2012 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2012 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.3962
CY2013 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.4291
CY2014 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.1771
CY2012 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.0189
CY2013 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.0182
CY2014 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.0199
CY2012 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0673
CY2013 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0479
CY2014 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.3275
CY2012 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.0000
CY2013 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.0169
CY2014 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.0549
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5488000 USD
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8909000 USD
CY2014 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y0M25D
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
13843000 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
14597000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
15000000 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
15000000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1157000 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
403000 USD
CY2012 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-1000 USD
CY2013 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-32000 USD
CY2014 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-158000 USD
CY2012 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1062000 USD
CY2013 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-3398000 USD
CY2014 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2012Q4 us-gaap Goodwill
Goodwill
8297000 USD
CY2013Q4 us-gaap Goodwill
Goodwill
10328000 USD
CY2014Q4 us-gaap Goodwill
Goodwill
23761000 USD
CY2012Q2 us-gaap Goodwill
Goodwill
8000000 USD
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-52281000 USD
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-64351000 USD
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13543000 USD
CY2012 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-442000 USD
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
173000 USD
CY2012 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2013 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2012 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-16778000 USD
CY2013 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-472000 USD
CY2013 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
10244000 USD
CY2014 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
14254000 USD
CY2012 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2239000 USD
CY2013 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
10238000 USD
CY2014 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7776000 USD
CY2013 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-400000 USD
CY2014 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-400000 USD
CY2014 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
6713000 USD
CY2012 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
10832000 USD
CY2013 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3480000 USD
CY2014 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
13706000 USD
CY2012 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-106000 USD
CY2013 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
1047000 USD
CY2014 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
2352000 USD
CY2012 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
59000 USD
CY2013 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
972000 USD
CY2014 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1447000 USD
CY2012 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
224000 USD
CY2013 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
110000 USD
CY2014 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-124000 USD
CY2012 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
2000000 USD
CY2013 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
1100000 USD
CY2014 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
400000 USD
CY2012 us-gaap Interest Expense
InterestExpense
1807000 USD
CY2013 us-gaap Interest Expense
InterestExpense
7253000 USD
CY2014 us-gaap Interest Expense
InterestExpense
8278000 USD
CY2012 us-gaap Interest Paid
InterestPaid
4229000 USD
CY2013 us-gaap Interest Paid
InterestPaid
3500000 USD
CY2014 us-gaap Interest Paid
InterestPaid
5193000 USD
CY2013Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
3946000 USD
CY2014Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
11383000 USD
CY2013Q4 us-gaap Inventory Net
InventoryNet
15557000 USD
CY2014Q4 us-gaap Inventory Net
InventoryNet
29263000 USD
CY2013Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
5290000 USD
CY2014Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
9263000 USD
CY2013Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
6321000 USD
CY2014Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
8617000 USD
CY2012 us-gaap Investment Income Interest
InvestmentIncomeInterest
275000 USD
CY2013 us-gaap Investment Income Interest
InvestmentIncomeInterest
259000 USD
CY2014 us-gaap Investment Income Interest
InvestmentIncomeInterest
382000 USD
CY2013Q4 us-gaap Liabilities
Liabilities
128571000 USD
CY2014Q4 us-gaap Liabilities
Liabilities
154927000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
169820000 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
326072000 USD
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
53033000 USD
CY2014Q4 us-gaap Operating Expenses
OperatingExpenses
53873000 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
121943000 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
140010000 USD
CY2013Q4 us-gaap Long Term Debt
LongTermDebt
98961000 USD
CY2014Q4 us-gaap Long Term Debt
LongTermDebt
103100000 USD
CY2013Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
120000000 USD
CY2014Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
120000000 USD
CY2013Q4 us-gaap Long Term Investments
LongTermInvestments
0 USD
CY2014Q4 us-gaap Long Term Investments
LongTermInvestments
24431000 USD
CY2012 us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
-36042000 USD
CY2013 us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
2389000 USD
CY2014 us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
25005000 USD
CY2012 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
63610000 USD
CY2013 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
89165000 USD
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
118875000 USD
CY2012 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-29522000 USD
CY2013 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-43560000 USD
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-119339000 USD
CY2012 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-70130000 USD
CY2013 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-43216000 USD
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
25469000 USD
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-52281000 USD
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-23138000 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-14031000 USD
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-14784000 USD
CY2013Q4 us-gaap Net Income Loss
NetIncomeLoss
-11956000 USD
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-63909000 USD
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-11477000 USD
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-5037000 USD
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-3004000 USD
CY2014Q4 us-gaap Net Income Loss
NetIncomeLoss
5802000 USD
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-13716000 USD
CY2012 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2983000 USD
CY2013 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-11062000 USD
CY2014 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-8378000 USD
CY2014 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2007Q1 us-gaap Off Market Lease Unfavorable
OffMarketLeaseUnfavorable
3300000 USD
CY2012 us-gaap Operating Expenses
OperatingExpenses
88382000 USD
CY2013Q1 us-gaap Operating Expenses
OperatingExpenses
30232000 USD
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
29151000 USD
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
36073000 USD
CY2013Q4 us-gaap Operating Expenses
OperatingExpenses
43384000 USD
CY2013 us-gaap Operating Expenses
OperatingExpenses
138840000 USD
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
45920000 USD
CY2014Q2 us-gaap Operating Expenses
OperatingExpenses
50007000 USD
CY2014 us-gaap Operating Expenses
OperatingExpenses
202833000 USD
CY2012 us-gaap Operating Income Loss
OperatingIncomeLoss
-49298000 USD
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-53289000 USD
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-5165000 USD
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
48177000 USD
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
6133000 USD
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
7876000 USD
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
7660000 USD
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
7459000 USD
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
7263000 USD
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
11786000 USD
CY2012 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
4800000 USD
CY2013 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
4900000 USD
CY2014 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
4900000 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3402000 USD
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2588000 USD
CY2012 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
12000 USD
CY2013 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-22000 USD
CY2014 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-85000 USD
CY2012 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
12000 USD
CY2013 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-22000 USD
CY2014 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-85000 USD
CY2012 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
12000 USD
CY2013 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-22000 USD
CY2014 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-85000 USD
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3190000 USD
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5409000 USD
CY2012 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-111000 USD
CY2013 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-47000 USD
CY2014 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-159000 USD
CY2012 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
1365000 USD
CY2013 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
7191000 USD
CY2014 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 USD
CY2012 us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
0 USD
CY2013 us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
0 USD
CY2014 us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
24463000 USD
CY2012 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
18257000 USD
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12794000 USD
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
21889000 USD
CY2012 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
54047000 USD
CY2013 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
114299000 USD
CY2014 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
139840000 USD
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2819000 USD
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4461000 USD
CY2012 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
CY2013 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
120000000 USD
CY2014Q2 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
110500000 USD
CY2012Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
62900000 USD
CY2012 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
27500000 USD
CY2013 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
CY2012 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1000 USD
CY2013 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
CY2014 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
CY2012 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
53120000 USD
CY2013 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
85564000 USD
CY2014 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
80286000 USD
CY2012 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
870000 USD
CY2013 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3856000 USD
CY2014 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
7239000 USD
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
60758000 USD
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
80746000 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
48182000 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
60632000 USD
CY2012 us-gaap Repayments Of Debt
RepaymentsOfDebt
26250000 USD
CY2013 us-gaap Repayments Of Debt
RepaymentsOfDebt
27500000 USD
CY2014 us-gaap Repayments Of Debt
RepaymentsOfDebt
0 USD
CY2012 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9937000 USD
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
21560000 USD
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18731000 USD
CY2013Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1633000 USD
CY2014Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1509000 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-296429000 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-310145000 USD
CY2012 us-gaap Revenues
Revenues
39084000 USD
CY2013Q1 us-gaap Revenues
Revenues
11587000 USD
CY2013Q2 us-gaap Revenues
Revenues
17141000 USD
CY2013Q3 us-gaap Revenues
Revenues
23259000 USD
CY2013Q4 us-gaap Revenues
Revenues
33564000 USD
CY2013 us-gaap Revenues
Revenues
85551000 USD
CY2014Q1 us-gaap Revenues
Revenues
36662000 USD
CY2014Q2 us-gaap Revenues
Revenues
47165000 USD
CY2014Q3 us-gaap Revenues
Revenues
52048000 USD
CY2014Q4 us-gaap Revenues
Revenues
61793000 USD
CY2012 us-gaap Royalty Revenue
RoyaltyRevenue
2503000 USD
CY2013 us-gaap Royalty Revenue
RoyaltyRevenue
2623000 USD
CY2014 us-gaap Royalty Revenue
RoyaltyRevenue
2855000 USD
CY2014 us-gaap Revenues
Revenues
197668000 USD
CY2012 us-gaap Royalty Expense
RoyaltyExpense
278000 USD
CY2013 us-gaap Royalty Expense
RoyaltyExpense
623000 USD
CY2014 us-gaap Royalty Expense
RoyaltyExpense
323000 USD
CY2012 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
18191000 USD
CY2013 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
81956000 USD
CY2014 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
193526000 USD
CY2012 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
46306000 USD
CY2013 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
62508000 USD
CY2014 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
106662000 USD
CY2012 us-gaap Share Based Compensation
ShareBasedCompensation
4776000 USD
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
11513000 USD
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
24822000 USD
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
8129537 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1629175 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
6500362 shares
CY2014Q4 us-gaap Share Price
SharePrice
88.66
CY2012Q2 us-gaap Share Price
SharePrice
9.75
CY2014Q2 us-gaap Share Price
SharePrice
64.00
CY2013Q4 us-gaap Short Term Investments
ShortTermInvestments
59637000 USD
CY2014Q4 us-gaap Short Term Investments
ShortTermInvestments
119138000 USD
CY2014 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
15722 shares
CY2014Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1840000 shares
CY2012 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
770000 USD
CY2013 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3856000 USD
CY2014 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
7239000 USD
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
48269000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
65855000 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
41249000 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
171145000 USD
CY2013Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
0 shares
CY2014Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
0 shares
CY2012 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
20700000 USD
CY2013 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
17500000 USD
CY2014 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
9900000 USD
CY2012 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
30332000 shares
CY2013 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
33182000 shares
CY2014 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
35299000 shares
CY2012 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30332000 shares
CY2013 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33182000 shares
CY2014 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35299000 shares
CY2014 us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">RECENT ACCOUNTING PRONOUNCEMENTS</font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2014, the Financial Accounting Standards Board, or FASB, issued Accounting Standards Update 2014-09,&#160;</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers</font><font style="font-family:inherit;font-size:10pt;">, which requires that an entity recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to its customers. In order to achieve this core principle, an entity should apply the following steps: (1) identify the contract(s) with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract and (5) recognize revenue when (or as) the entity satisfies a performance obligation. This update will replace existing revenue recognition guidance under GAAP when it becomes effective for the Company beginning January 1, 2017, with early adoption not permitted. The updated standard will permit the use of either the retrospective or cumulative effect transition method. The Company is currently evaluating the impact of this update on its consolidated financial statements.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2014, the FASB issued Accounting Standards Update 2014-15, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Presentation of Financial Statements&#8212;Going Concern</font><font style="font-family:inherit;font-size:10pt;">, which requires that management of an entity should evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity&#8217;s ability to continue as a going concern within one year after the date that the financial statements are issued or available to be issued. This update will become effective beginning January 1, 2017, with early adoption permitted. The provisions of this standard are not expected to significantly impact the Company.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other pronouncements issued by the FASB or other authoritative accounting standards groups with future effective dates are either not applicable or not significant to the consolidated financial statements of the Company.</font></div></div>
CY2014 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, including disclosure of contingent assets and contingent liabilities, at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Estimates are used for, among other things, revenue recognition, impairment of long-lived assets, stock-based compensation and valuation of deferred tax assets. The Company&#8217;s critical accounting policies are those that are both most important to the Company&#8217;s consolidated financial condition and results of operations and require the most difficult, subjective or complex judgments on the part of management in their application, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. Because of the uncertainty of factors surrounding the estimates or judgments used in the preparation of the consolidated financial statements, actual results could differ from these estimates.</font></div></div>

Files In Submission

Name View Source Status
0001396814-15-000003-index-headers.html Edgar Link pending
0001396814-15-000003-index.html Edgar Link pending
0001396814-15-000003.txt Edgar Link pending
0001396814-15-000003-xbrl.zip Edgar Link pending
color123114charta01.jpg Edgar Link pending
exhibit2111.htm Edgar Link pending
exhibit2311.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
pcrx-12312014x10k.htm Edgar Link pending
pcrx-12312014xex311.htm Edgar Link pending
pcrx-12312014xex312.htm Edgar Link pending
pcrx-12312014xex321.htm Edgar Link pending
pcrx-12312014xex322.htm Edgar Link pending
pcrx-20141231.xml Edgar Link completed
pcrx-20141231.xsd Edgar Link pending
pcrx-20141231_cal.xml Edgar Link unprocessable
pcrx-20141231_def.xml Edgar Link unprocessable
pcrx-20141231_lab.xml Edgar Link unprocessable
pcrx-20141231_pre.xml Edgar Link unprocessable
pipelinea04.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending